To download the full report, click here.

America's biopharmaceutical companies are developing more than 1,100 medicines and vaccines for cancer, all of which are in clinical trials or awaiting review by the U.S. Food and Drug Administration (FDA). The report outlines all medicines including their product name, sponsor, indication and development/phase.